- Market Realist•4 hours ago
With the launch of Orkambi, which caters to a larger population base, Kalydeco’s contribution dropped to 42.8% in 1Q16 from 93.3% in 2Q15.
Vertex Pharmaceuticals IncorporatedNasdaqGS
|Bid||95.40 x 200|
|Ask||95.42 x 100|
|52wk Range||75.90 - 143.45|
|Day's Range||93.46 - 95.85|
|Avg Vol (3m)||1,666,087|
As of 12:51 PM EDT. NasdaqGS Real Time Price. Market open.